1. Home
  2. SCLX vs DHX Comparison

SCLX vs DHX Comparison

Compare SCLX & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$9.03

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Logo DHI Group Inc.

DHX

DHI Group Inc.

HOLD

Current Price

$2.58

Market Cap

79.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
DHX
Founded
2011
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
79.7M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
SCLX
DHX
Price
$9.03
$2.58
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
80.8K
612.0K
Earning Date
11-14-2025
02-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,360,000.00
$127,826,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
$7.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$1.21
52 Week High
$34.27
$3.34

Technical Indicators

Market Signals
Indicator
SCLX
DHX
Relative Strength Index (RSI) 34.71 81.27
Support Level $7.82 $1.80
Resistance Level $10.41 $2.20
Average True Range (ATR) 1.02 0.17
MACD 0.05 0.06
Stochastic Oscillator 20.56 88.78

Price Performance

Historical Comparison
SCLX
DHX

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

Share on Social Networks: